{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:00:16Z","timestamp":1792720816503,"version":"4.5.0"},"reference-count":260,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2015,8,24]],"date-time":"2015-08-24T00:00:00Z","timestamp":1440374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.mdpi.com"],"crossmark-restriction":true},"short-container-title":["Molecules"],"abstract":"<jats:p>Recently, research into the development of new antimicrobial agents has been driven by the increase in resistance to traditional antibiotics and Emerging Infectious Diseases. Antimicrobial peptides (AMPs) are promising candidates as alternatives to current antibiotics in the treatment and prevention of microbial infections. AMPs are produced by all known living species, displaying direct antimicrobial killing activity and playing an important role in innate immunity. To date, more than 2000 AMPs have been discovered and many of these exhibit broad-spectrum antibacterial, antiviral and anti-parasitic activity. Neglected tropical diseases (NTDs) are caused by a variety of pathogens and are particularly wide-spread in low-income and developing regions of the world. Alternative, cost effective treatments are desperately needed to effectively battle these medically diverse diseases. AMPs have been shown to be effective against a variety of NTDs, including African trypanosomes, leishmaniosis and Chagas disease, trachoma and leprosy. In this review, the potential of selected AMPs to successfully treat a variety of NTD infections will be critically evaluated.<\/jats:p>","DOI":"10.3390\/molecules200815392","type":"journal-article","created":{"date-parts":[[2015,8,25]],"date-time":"2015-08-25T02:34:23Z","timestamp":1440470063000},"page":"15392-15433","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["The Potential Use of Natural and Structural Analogues of Antimicrobial Peptides in the Fight against Neglected Tropical Diseases"],"prefix":"10.3390","volume":"20","author":[{"given":"Ang\u00e9lique","family":"Lewies","sequence":"first","affiliation":[{"name":"Centre of Excellence for Pharmaceutical Sciences (PHARMACEN), North-West University, Potchefstroom 2520, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Wentzel","sequence":"additional","affiliation":[{"name":"Centre of Excellence for Pharmaceutical Sciences (PHARMACEN), North-West University, Potchefstroom 2520, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garmi","family":"Jacobs","sequence":"additional","affiliation":[{"name":"Centre of Excellence for Pharmaceutical Sciences (PHARMACEN), North-West University, Potchefstroom 2520, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0954-2976","authenticated-orcid":false,"given":"Lissinda","family":"Du Plessis","sequence":"additional","affiliation":[{"name":"Centre of Excellence for Pharmaceutical Sciences (PHARMACEN), North-West University, Potchefstroom 2520, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2015,8,24]]},"reference":[{"key":"ref_1","unstructured":"WHO Neglected Tropical Diseases. Available online: http:\/\/www.who.int\/neglected_diseases\/diseases\/en\/."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Hotez, P.J., Molyneuz, D.H., Fenwick, A., Ottesen, E., Ehrlich Sachs, S., and Sachs, J.D. (2006). Incorporating a rapid-impact package for Neglected tropical diseases with programs for HIV\/AIDS, tuberculosis, maleria. PLoS Med., 3.","DOI":"10.1371\/journal.pmed.0030102"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/bmb\/ldp046","article-title":"Neglected tropical diseases","volume":"93","author":"Feasey","year":"2010","journal-title":"Br. Med. Bull."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nbt.2572","article-title":"Antimicrobial peptides stage a comeback","volume":"31","author":"Fox","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0167-7799(97)01156-6","article-title":"Cationic peptides: A new source of antibiotics","volume":"16","author":"Hancock","year":"1998","journal-title":"Trends Biotechnol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s15010-004-4001-4","article-title":"Nontuberculous mycobacterial infections: A clinical review","volume":"32","author":"Wagner","year":"2004","journal-title":"Infection"},{"key":"ref_7","first-page":"505","article-title":"A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs","volume":"30","author":"Gordon","year":"2005","journal-title":"Curr. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/nbt1267","article-title":"Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies","volume":"24","author":"Hancock","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"ref_9","unstructured":"Jones, E., Salin, V., and Williams, G.W. Nisin and the Market for Commercial Bacteriocins. http:\/\/wwww.ageconsearch.umn.edu\/bitstream\/90779\/2\/CP%2001%2005%20Nisin%20Report.pdf."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1128\/CMR.00056-05","article-title":"Peptide antimicrobial agents","volume":"19","author":"Jenssen","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.actatropica.2014.11.015","article-title":"Isolation, identification and functional profile of excretory-secretory peptides from Onchocerca ochengi","volume":"142","author":"Eberle","year":"2015","journal-title":"Acta Tropica"},{"key":"ref_12","unstructured":"Wang, G., Li, X., and Wang, Z. The Antimicrobial Peptide Database. Available online: http:\/\/wwww.aps.unmc.edu\/AP\/main.php."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"D933","DOI":"10.1093\/nar\/gkn823","article-title":"APD2: The updated antimicrobial peptide database and its application in peptide design","volume":"37","author":"Wang","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"D590","DOI":"10.1093\/nar\/gkh025","article-title":"APD: The Antimicrobial Peptide Database","volume":"32","author":"Wang","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0734-9750(03)00077-6","article-title":"Ribosomally synthesized peptides with antimicrobial properties: Biosynthesis, structure, function, and applications","volume":"21","author":"Papagianni","year":"2003","journal-title":"Biotechnol. Adv."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1021\/mp700137g","article-title":"Nonribosomal peptide synthetases involved in the production of medically relevant natural products","volume":"5","author":"Felnagle","year":"2008","journal-title":"Mol. Pharm."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/cbic.201300778","article-title":"Baceridin, a cyclic hexapeptide from an epiphytic Bacillus strain, inhibits the proteasome","volume":"15","author":"Niggemann","year":"2014","journal-title":"Chem. Biol. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3390\/ph8010123","article-title":"Antimicrobial peptides in 2014","volume":"8","author":"Wang","year":"2015","journal-title":"Pharmaceuticals"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1128\/IAI.71.7.3730-3739.2003","article-title":"Staphylococcus aureus susceptibility to innate antimicrobial peptides, beta-defensins and CAP18, expressed by human keratinocytes","volume":"71","author":"Midorikawa","year":"2003","journal-title":"Infect. Immun."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0966-842X(00)01823-0","article-title":"The role of cationic antimicrobial peptides in innate host defences","volume":"8","author":"Hancock","year":"2000","journal-title":"Trends Microbiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1128\/JVI.05738-11","article-title":"Sensing of RNA viruses: A review of innate immune receptors involved in recognizing RNA virus invasion","volume":"86","author":"Jensen","year":"2012","journal-title":"J. Virol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1128\/JVI.01080-07","article-title":"Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity","volume":"82","author":"Loo","year":"2008","journal-title":"J. Virol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nrmicro1273","article-title":"Bacteriocins: Developing innate immunity for food","volume":"3","author":"Cotter","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nrmicro1098","article-title":"Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria?","volume":"3","author":"Brogden","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.bbamem.2008.09.013","article-title":"Control of cell selectivity of antimicrobial peptides","volume":"1788","author":"Matsuzaki","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.biochi.2010.02.023","article-title":"Structural determinants of host defense peptides for antimicrobial activity and target cell selectivity","volume":"92","author":"Takahashi","year":"2010","journal-title":"Biochimie"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2174\/138920309789630589","article-title":"Anionic antimicrobial peptides from eukaryotic organisms","volume":"10","author":"Harris","year":"2009","journal-title":"Curr. Protein Pept. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"6566","DOI":"10.3390\/ijms12106566","article-title":"The potential of antimicrobial peptides as biocides","volume":"12","author":"Laverty","year":"2011","journal-title":"Int. J. Mol. Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0924-8579(03)00180-8","article-title":"Antimicrobial peptides in animals and their role in host defences","volume":"22","author":"Brogden","year":"2003","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s13238-010-0004-3","article-title":"Alpha-helical cationic antimicrobial peptides: Relationships of structure and function","volume":"1","author":"Huang","year":"2010","journal-title":"Protein Cell"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1365-3083.1998.00343.x","article-title":"Gene-encoded peptide antibiotics and the concept of innate immunity: An update review","volume":"48","author":"Boman","year":"1998","journal-title":"Scand. J. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/nar\/gkt381","article-title":"Scalable web services for the PSIPRED Protein Analysis Workbench","volume":"41","author":"Buchan","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Vale, N., Aguiar, L., and Gomes, P. (2014). Antimicrobial peptides: A new class of antimalarial drugs?. Front. Pharmacol., 5.","DOI":"10.3389\/fphar.2014.00275"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/BF02144681","article-title":"Chemical structure of circulin A","volume":"21","author":"Fujikawa","year":"1965","journal-title":"Experientia"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1006\/jmbi.1999.3383","article-title":"Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif","volume":"294","author":"Craik","year":"1999","journal-title":"J. Mol. Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"27014","DOI":"10.1074\/jbc.R112.346098","article-title":"Theta-Defensins: Cyclic peptides with endless potential","volume":"287","author":"Lehrer","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.vetmic.2011.03.028","article-title":"Avian cathelicidins: Paradigms for the development of anti-infectives","volume":"153","author":"Molhoek","year":"2011","journal-title":"Vet. Microbiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cimid.2012.01.006","article-title":"Functional analysis and induction of four novel goose (Anser cygnoides) avian beta-defensins in response to salmonella enteritidis infection","volume":"35","author":"Ma","year":"2012","journal-title":"Comp. Immunol. Microbiol. Infecti. Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.cbpb.2009.01.003","article-title":"The salmonid cathelicidins: A gene family with highly varied C-terminal antimicrobial domains","volume":"152","author":"Scocchi","year":"2009","journal-title":"Comp. Biochem. Physiol. B Biochem. Mol. Biol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1016\/j.molimm.2009.07.018","article-title":"Characterization of three novel beta-defensin antimicrobial peptides in rainbow trout (Oncorhynchus mykiss)","volume":"46","author":"Casadei","year":"2009","journal-title":"Mol. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.acthis.2015.02.004","article-title":"Immunocytochemical detection of beta-defensins and cathelicidins in the secretory granules of the tongue in the lizard Anolis carolinensis","volume":"117","author":"Alibardi","year":"2015","journal-title":"Acta Histochem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.peptides.2008.06.008","article-title":"Identification and characterization of novel reptile cathelicidins from elapid snakes","volume":"29","author":"Zhao","year":"2008","journal-title":"Peptides"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/prot.21378","article-title":"Structure-based protein engineering for alpha-amylase inhibitory activity of plant defensin","volume":"68","author":"Lin","year":"2007","journal-title":"Proteins"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0969-2126(01)00177-0","article-title":"Refined three-dimensional solution structure of insect defensin A","volume":"3","author":"Cornet","year":"1995","journal-title":"Structure"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1286-4579(02)01549-6","article-title":"Cathelicidins: Microbicidal activity, mechanisms of action, and roles in innate immunity","volume":"4","author":"Ramanathan","year":"2002","journal-title":"Microbes Infect."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nri1180","article-title":"Defensins: Antimicrobial peptides of innate immunity","volume":"3","author":"Ganz","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cytogfr.2014.12.005","article-title":"Defensins: \u201cSimple\u201d antimicrobial peptides or broad-spectrum molecules?","volume":"26","author":"Hubert","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cellimm.2012.11.009","article-title":"A comprehensive summary of LL-37, the factotum human cathelicidin peptide","volume":"280","author":"Vandamme","year":"2012","journal-title":"Cellular Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-5793(95)01050-O","article-title":"Cathelicidins: A novel protein family with a common proregion and a variable C-terminal antimicrobial domain","volume":"374","author":"Zanetti","year":"1995","journal-title":"FEBS Lett."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"4230","DOI":"10.1074\/jbc.275.6.4230","article-title":"Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity","volume":"275","author":"Feder","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"6388","DOI":"10.1021\/bi0026066","article-title":"The effect of cyclization of magainin 2 and melittin analogues on structure, function, and model membrane interactions: Implication to their mode of action","volume":"40","author":"Unger","year":"2001","journal-title":"Biochemistry"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1124\/pr.55.1.2","article-title":"Mechanisms of antimicrobial peptide action and resistance","volume":"55","author":"Yeaman","year":"2003","journal-title":"Pharmacol. Rev."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.2174\/138945012802002393","article-title":"Antimicrobial peptide action on parasites","volume":"13","author":"Torrent","year":"2012","journal-title":"Curr. Drug Targets"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.bbamem.2009.06.008","article-title":"Fungicidal effect of antimicrobial peptide arenicin-1","volume":"1788","author":"Park","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.peptides.2010.07.028","article-title":"A carpet-based mechanism for direct antimicrobial peptide activity against vaccinia virus membranes","volume":"31","author":"Dean","year":"2010","journal-title":"Peptides"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nri1860","article-title":"Defensins in innate antiviral immunity","volume":"6","author":"Klotman","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1128\/AAC.49.8.3114-3121.2005","article-title":"Functional interrelationships between cell membrane and cell wall in antimicrobial peptide-mediated killing of Staphylococcus aureus","volume":"49","author":"Xiong","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1038\/srep01557","article-title":"Imaging the action of antimicrobial peptides on living bacterial cells","volume":"3","author":"Gee","year":"2013","journal-title":"Sci. Rep."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.peptides.2003.08.023","article-title":"The relationship between peptide structure and antibacterial activity","volume":"24","author":"Powers","year":"2003","journal-title":"Peptides"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/jss.400020504","article-title":"A molecular model of membrane excitability","volume":"2","author":"Baumann","year":"1974","journal-title":"J. Supramol. Struct."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/S0006-3495(01)75802-X","article-title":"Barrel-stave model or toroidal model? A case study on melittin pores","volume":"81","author":"Yang","year":"2001","journal-title":"Biophys. J."},{"key":"ref_63","first-page":"1123","article-title":"Interaction between antimicrobial peptides (AMPs) and their primary target, the biomembranes","volume":"Volume 2","year":"2013","journal-title":"Microbial Pathogens and Strategies for Combating Them: Science, Technology and Education"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0005-2736(97)00051-5","article-title":"Interactions of an antimicrobial peptide, magainin 2, with outer and inner membranes of Gram-negative bacteria","volume":"1327","author":"Matsuzaki","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1042\/BJ20110056","article-title":"Inducing toxicity by introducing a leucine-zipper-like motif in frog antimicrobial peptide, magainin 2","volume":"436","author":"Pandey","year":"2011","journal-title":"Biochem. J."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"4916","DOI":"10.1128\/IAI.69.8.4916-4922.2001","article-title":"Diversity in antistaphylococcal mechanisms among membrane-targeting antimicrobial peptides","volume":"69","author":"Koo","year":"2001","journal-title":"Infect. Immun."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.bbagen.2006.09.006","article-title":"Dual mode of action of Bac7, a proline-rich antibacterial peptide","volume":"1760","author":"Podda","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"6483","DOI":"10.1111\/j.1742-4658.2009.07359.x","article-title":"Multifunctional host defense peptides: Intracellular-targeting antimicrobial peptides","volume":"276","author":"Nicolas","year":"2009","journal-title":"FEBS J."},{"key":"ref_69","first-page":"697","article-title":"Antibacterial peptides and proteins with multiple cellular targets","volume":"11","author":"Otvos","year":"2005","journal-title":"J. Pept. Sci. An Off. Publ. Europ. Pept. Soc."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2174\/1389203053027494","article-title":"A re-evaluation of the role of host defence peptides in mammalian immunity","volume":"6","author":"Bowdish","year":"2005","journal-title":"Curr. Protein Pept. Sci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s00284-008-9241-6","article-title":"Effects of cations and pH on antimicrobial activity of thanatin and s-thanatin against Escherichia coli ATCC25922 and B. subtilis ATCC 21332","volume":"57","author":"Wu","year":"2008","journal-title":"Curr. Microbiol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1074\/jbc.273.6.3718","article-title":"Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37","volume":"273","author":"Johansson","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"224","DOI":"10.2174\/1568010033484115","article-title":"Epithelial cell-derived antibacterial peptides human beta-defensins and cathelicidin: Multifunctional activities on mast cells","volume":"2","author":"Niyonsaba","year":"2003","journal-title":"Curr. Drug Targets Inflamm. Allergy"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"ii17","DOI":"10.1136\/ard.62.suppl_2.ii17","article-title":"Roles of antimicrobial peptides such as defensins in innate and adaptive immunity","volume":"62","author":"Oppenheim","year":"2003","journal-title":"Annals Rheum. Dis."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.4049\/jimmunol.169.7.3883","article-title":"The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses","volume":"169","author":"Scott","year":"2002","journal-title":"J. Immunol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"6690","DOI":"10.4049\/jimmunol.171.12.6690","article-title":"The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor","volume":"171","author":"Tjabringa","year":"2003","journal-title":"J. Immunol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev.immunol.22.012703.104603","article-title":"Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense","volume":"22","author":"Yang","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"4922","DOI":"10.1128\/iai.64.12.4922-4927.1996","article-title":"Antiendotoxin activity of cationic peptide antimicrobial agents","volume":"64","author":"Gough","year":"1996","journal-title":"Infect. Immun."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1128\/AAC.48.5.1526-1533.2004","article-title":"Antibacterial activities of rhodamine B-conjugated gelsolin-derived peptides compared to those of the antimicrobial peptides cathelicidin LL37, magainin II, and melittin","volume":"48","author":"Bucki","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.coph.2006.04.006","article-title":"Antibacterial peptides for therapeutic use: Obstacles and realistic outlook","volume":"6","author":"Marr","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.peptides.2004.10.004","article-title":"Deletion of two C-terminal Gln residues of 12-26-residue fragment of melittin improves its antimicrobial activity","volume":"26","author":"Sun","year":"2005","journal-title":"Peptides"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.1021\/bi00233a006","article-title":"Hemolytic and antimicrobial activities of the twenty-four individual omission analogues of melittin","volume":"30","author":"Blondelle","year":"1991","journal-title":"Biochemistry"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"55042","DOI":"10.1074\/jbc.M408881200","article-title":"Dissection of antibacterial and toxic activity of melittin: A leucine zipper motif plays a crucial role in determining its hemolytic activity but not antibacterial activity","volume":"279","author":"Asthana","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1007\/s11033-013-2900-0","article-title":"Design, characterization and expression of a novel hybrid peptides melittin (1-13)-LL37 (17-30)","volume":"41","author":"Wu","year":"2014","journal-title":"Mol. Biol. Rep."},{"key":"ref_85","first-page":"217","article-title":"Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals?","volume":"38","author":"Brogden","year":"2011","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nrmicro908","article-title":"Can innate immunity be enhanced to treat microbial infections?","volume":"2","author":"Finlay","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"6734","DOI":"10.3390\/molecules18066734","article-title":"Eudragit(R) L100\/N-trimethylchitosan chloride microspheres for oral insulin delivery","volume":"18","author":"Marais","year":"2013","journal-title":"Molecules"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1021\/bm0703923","article-title":"Oral bioavailability of insulin contained in polysaccharide nanoparticles","volume":"8","author":"Sarmento","year":"2007","journal-title":"Biomacromolecules"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"5791","DOI":"10.1021\/nn400683s","article-title":"Hybrid melittin cytolytic Peptide-driven ultrasmall lipid nanoparticles block melanoma growth in vivo","volume":"7","author":"Huang","year":"2013","journal-title":"ACS Nano"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Piras, A.M., Maisetta, G., Sandreschi, S., Gazzarri, M., Bartoli, C., Grassi, L., Esin, S., Chiellini, F., and Batoni, G. (2015). Chitosan nanoparticles loaded with the antimicrobial peptide temporin B exert a long-term antibacterial activity in vitro against clinical isolates of Staphylococcus epidermidis. Front. Microbiol., 6.","DOI":"10.3389\/fmicb.2015.00372"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"6366","DOI":"10.1128\/AAC.01180-12","article-title":"In vitro activities of antibiotics and antimicrobial cationic peptides alone and in combination against methicillin-resistant Staphylococcus aureus biofilms","volume":"56","author":"Mataraci","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.pt.2006.06.004","article-title":"Reconsidering the underestimated burden caused by Neglected tropical diseases","volume":"22","author":"Engels","year":"2006","journal-title":"Trends Parasitol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1097\/01.aids.0000189846.90946.5d","article-title":"The effects of maternal helminth and malaria infections on mother-to-child HIV transmission","volume":"19","author":"Gallagher","year":"2005","journal-title":"Aids"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMra064142","article-title":"Control of Neglected tropical diseases","volume":"357","author":"Hotez","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/S0140-6736(09)60233-6","article-title":"Rescuing the bottom billion through control of Neglected tropical diseases","volume":"373","author":"Hotez","year":"2009","journal-title":"Lancet"},{"key":"ref_96","unstructured":"Norris, J., Adelman, C., Spantchak, Y., and Marano, K. (2012). Social and Economic Impact Review on Neglected Tropical Diseases, Hudson Institute\u2019s Center for Science in Public Policy."},{"key":"ref_97","unstructured":"WHO Antimicrobial Resistance: Fact sheet N\u00b0 194. Available online: http:\/\/www.who.int\/mediacentre\/factsheets\/fs194\/en\/."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"77","DOI":"10.59566\/IJBS.2010.6077","article-title":"The post-antibiotic era: Promising developments in the therapy of infectious diseases","volume":"6","author":"Zucca","year":"2010","journal-title":"Int. J. Biomed. Sci.: IJBS"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"d387","DOI":"10.2741\/A199","article-title":"Processing of mycobacterial lipids and effects on host responsiveness","volume":"2","author":"Barrow","year":"1997","journal-title":"Front. Biosci. A J. Virtual Lib."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"55","DOI":"10.20506\/rst.20.1.1264","article-title":"Treatment of mycobacterial infections","volume":"20","author":"Barrow","year":"2001","journal-title":"Rev. Scientifique Tech."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.peptides.2010.06.016","article-title":"The human cathelicidin hCAP18\/LL-37: A multifunctional peptide involved in mycobacterial infections","volume":"31","year":"2010","journal-title":"Peptides"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1128\/AAC.42.9.2206","article-title":"Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils","volume":"42","author":"Turner","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.coi.2008.06.008","article-title":"Antimicrobial peptides and self-DNA in autoimmune skin inflammation","volume":"20","author":"Gilliet","year":"2008","journal-title":"Curr. Opin. Immunol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1126\/science\/1109759","article-title":"On the origin of leprosy","volume":"308","author":"Monot","year":"2005","journal-title":"Science"},{"key":"ref_105","unstructured":"WHO Leprosy Fact Sheet N\u00b0 101. Available online: http:\/\/www.who.int\/mediacentre\/factsheets\/fs101\/en\/."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e1869","DOI":"10.1371\/journal.pntd.0001869","article-title":"Human beta-defensin 3 is up-regulated in cutaneous leprosy type 1 reactions","volume":"6","author":"Cogen","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/003335490812300212","article-title":"Leprosy: Steps along the journey of eradication","volume":"123","author":"Bennett","year":"2008","journal-title":"Public Health Rep."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/35059006","article-title":"Massive gene decay in the leprosy bacillus","volume":"409","author":"Cole","year":"2001","journal-title":"Nature"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/31159","article-title":"Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence","volume":"393","author":"Cole","year":"1998","journal-title":"Nature"},{"key":"ref_110","first-page":"708","article-title":"The discovery of the leprosy bacillus","volume":"122","author":"Irgens","year":"2002","journal-title":"Tidsskr. Norske Laegeforening Tidsskr. Prakt. Med. Ny Raekke"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1086\/597070","article-title":"Functional haplotypes that produce normal ficolin-2 levels protect against clinical leprosy","volume":"199","author":"Kremsner","year":"2009","journal-title":"J. Infect. Dis."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/bmj.1.5688.89","article-title":"Experimental and clinical studies on rifampicin in treatment of leprosy","volume":"1","author":"Rees","year":"1970","journal-title":"Br. Med. J."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2217\/fmb.10.173","article-title":"Mycobacterium leprae-host-cell interactions and genetic determinants in leprosy: An overview","volume":"6","author":"Pinheiro","year":"2011","journal-title":"Future Microbiol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1086\/524688","article-title":"Toll-like receptor 2 (TLR2) polymorphisms are associated with reversal reaction in leprosy","volume":"197","author":"Bochud","year":"2008","journal-title":"J. Infect. Dis."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1126\/science.1123933","article-title":"Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response","volume":"311","author":"Liu","year":"2006","journal-title":"Science"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nm.2584","article-title":"MicroRNA-21 targets the vitamin D-dependent antimicrobial pathway in leprosy","volume":"18","author":"Liu","year":"2012","journal-title":"Nat. Med."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1172\/JCI200420945","article-title":"IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin","volume":"113","author":"Nemeth","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.micinf.2011.10.001","article-title":"Iron metabolism and the innate immune response to infection","volume":"14","author":"Johnson","year":"2012","journal-title":"Microbes Infect."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ijmm.2013.02.004","article-title":"Antibiotics and antibiotic resistance: A bitter fight against evolution","volume":"303","author":"Couce","year":"2013","journal-title":"Int. J. Med. Microbiol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2174\/092986710789957814","article-title":"Neglected diseases caused by bacterial infections","volume":"17","author":"Bechtle","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"ref_121","unstructured":"WHO Trachoma: Fact Sheet N\u00b0 382. Available online: http:\/\/www.who.int\/mediacentre\/factsheets\/fs382\/en\/."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.3201\/eid1011.040353","article-title":"Contribution of sex-linked biology and gender roles to disparities with trachoma","volume":"10","author":"Courtright","year":"2004","journal-title":"Emerg. Infect. Dis."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1128\/CMR.17.4.982-1011.2004","article-title":"Diagnosis and assessment of trachoma","volume":"17","author":"Solomon","year":"2004","journal-title":"Clin. Microbiol.Rev."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0140-6736(03)13914-1","article-title":"Trachoma","volume":"362","author":"Mabey","year":"2003","journal-title":"Lancet"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/bmb\/ldm034","article-title":"Trachoma: An overview","volume":"84","author":"Burton","year":"2007","journal-title":"Br. Med. Bull."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.3390\/molecules20034180","article-title":"Natural products for the treatment of trachoma and Chlamydia trachomatis","volume":"20","author":"Potroz","year":"2015","journal-title":"Molecules"},{"key":"ref_127","unstructured":"WHO Report of the 2nd Global Scientific Meeting on Trachoma. http:\/\/www.who.int\/blindness\/2nd%20GLOBAL%20SCIENTIFIC%20MEETING.pdf."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1056\/NEJMoa040979","article-title":"Mass treatment with single-dose azithromycin for trachoma","volume":"351","author":"Solomon","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Evans, J.R., and Solomon, A.W. (2011). Antibiotics for Trachoma. Cochrane Database Syst. Rev.","DOI":"10.1002\/14651858.CD001860.pub3"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1128\/AAC.49.3.1201-1202.2005","article-title":"Activity of cathelicidin peptides against Chlamydia spp","volume":"49","author":"Donati","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ddr.20329","article-title":"Cathelicidin peptide SMAP-29: Comprehensive review of its properties and potential as a novel class of antibiotics","volume":"70","author":"Dawson","year":"2009","journal-title":"Drug Dev. Res."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1089\/10430340260395875","article-title":"A model for antimicrobial gene therapy: Demonstration of human beta-defensin 2 antimicrobial activities in vivo","volume":"13","author":"Huang","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0924-8579(01)00479-4","article-title":"Induced expression of melittin, an antimicrobial peptide, inhibits infection by Chlamydia trachomatis and Mycoplasma hominis in a HeLa cell line","volume":"19","author":"Lazarev","year":"2002","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00203-012-0863-5","article-title":"Antimicrobial peptide from spider venom inhibits Chlamydia trachomatis infection at an early stage","volume":"195","author":"Lazarev","year":"2013","journal-title":"Arch. Microbiol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.bbrc.2005.10.028","article-title":"Effect of induced expression of an antimicrobial peptide melittin on Chlamydia trachomatis and Mycoplasma hominis infections in vivo","volume":"338","author":"Lazarev","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_136","unstructured":"Cox, F.E.G. (1996). Parasitic protozoa. Modern Parasitology: A Textbook of Parasitology, Blackwell Science Ltd. [2nd ed.]."},{"key":"ref_137","unstructured":"Spicer, J.W. (2000). Clinical Bacteriology, Mycology and Parasitology, Harcourt Publishers Ltd."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijpddr.2014.02.002","article-title":"Drug repurposing and human parasitic protozoan diseases","volume":"4","author":"Andrews","year":"2014","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.exppara.2010.02.006","article-title":"Interactions of antimicrobial peptides with Leishmania and trypanosomes and their functional role in host parasitism","volume":"126","author":"McGwire","year":"2010","journal-title":"Exp. Parasitol."},{"key":"ref_140","unstructured":"WHO Chagas Disease (American Trypanosomiasis). http:\/\/www.who.int\/chagas\/en\/."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1001\/jama.298.18.2171","article-title":"Evaluation and treatment of chagas disease in the United States: A systematic review","volume":"298","author":"Bern","year":"2007","journal-title":"JAMA"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1128\/AAC.05018-14","article-title":"Population pharmacokinetics of benznidazole in adult patients with chagas disease","volume":"59","author":"Soy","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/jeu.12184","article-title":"Recent clinical trials for the etiological treatment of chronic chagas disease: Advances, challenges and perspectives","volume":"62","author":"Urbina","year":"2015","journal-title":"J. Eukaryot. Microbiol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1017\/S0031182012000790","article-title":"Apis mellifera venom induces different cell death pathways in Trypanosoma cruzi","volume":"139","author":"Adade","year":"2012","journal-title":"Parasitology"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.toxicon.2013.03.011","article-title":"Melittin peptide kills Trypanosoma cruzi parasites by inducing different cell death pathways","volume":"69","author":"Adade","year":"2013","journal-title":"Toxicon"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.exppara.2010.02.016","article-title":"Trypanosoma cruzi: Synergistic cytotoxicity of multiple amphipathic anti-microbial peptides to T. cruzi and potential bacterial hosts","volume":"125","author":"Fieck","year":"2010","journal-title":"Exp. Parasitol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1128\/AAC.34.9.1824","article-title":"Magainin analogs effective against pathogenic protozoa","volume":"34","author":"Huang","year":"1990","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1096\/fasebj.2.13.3049204","article-title":"In vitro cytocidal effect of novel lytic peptides on Plasmodium falciparum and Trypanosoma cruzi","volume":"2","author":"Jaynes","year":"1988","journal-title":"FASEB J."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"49332","DOI":"10.1074\/jbc.M209289200","article-title":"Dermaseptins from Phyllomedusa oreades and Phyllomedusa distincta. Anti-Trypanosoma cruzi activity without cytotoxicity to mammalian cells","volume":"277","author":"Brand","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.exppara.2013.09.016","article-title":"Antimicrobial peptides isolated from Phyllomedusa nordestina (Amphibia) alter the permeability of plasma membrane of Leishmania and Trypanosoma cruzi","volume":"135","author":"Pinto","year":"2013","journal-title":"Exp. Parasitol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.exppara.2007.07.011","article-title":"Trypanocidal and leishmanicidal activities of different antimicrobial peptides (AMPs) isolated from aquatic animals","volume":"118","author":"Lofgren","year":"2008","journal-title":"Exp. Parasitol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/sj.bjp.0707354","article-title":"Human African trypanosomiasis: Pharmacololgical re-engagement with a neglected disease","volume":"152","author":"Barrett","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"ref_153","unstructured":"WHO Trypanosomiasis, Human African (Sleeping Sickness). http:\/\/www.who.int\/mediacentre\/factsheets\/fs259\/en\/."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0140-6736(09)60829-1","article-title":"Human African trypanosomiasis","volume":"375","author":"Brun","year":"2010","journal-title":"Lancet"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.biochi.2012.10.015","article-title":"Antibacterial and leishmanicidal activities of temporin-SHd, a 17-residue long membrane-damaging peptide","volume":"95","author":"Abbassi","year":"2013","journal-title":"Biochimie"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1086\/375747","article-title":"Killing of African trypanosomes by antimicrobial peptides","volume":"188","author":"McGwire","year":"2003","journal-title":"J. Infect. Dis."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1371\/journal.pntd.0000373","article-title":"Killing of trypanosomatid parasites by a modified bovine host defense peptide, BMAP-18","volume":"3","author":"Haines","year":"2009","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref_158","unstructured":"WHO Leishmaniasis Fact Sheet No. 375. February 2015. http:\/\/www.who.int\/mediacentre\/factsheets\/fs375\/en\/."},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"De Menezes, J.P., Guedes, C.E., Petersen, A.L., Fraga, D.B., and Veras, P.S. (2015). Advances in Development of New Treatment for Leishmaniasis. Biomed. Res. Int., 2015.","DOI":"10.1155\/2015\/815023"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1074\/jbc.M410795200","article-title":"Temporins, small antimicrobial peptides with leishmanicidal activity","volume":"280","author":"Mangoni","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_161","first-page":"751","article-title":"Studies on the antileishmanial properties of the antimicrobial peptides temporin A, B and 1Sa","volume":"17","author":"Chadbourne","year":"2011","journal-title":"J. Pept. Sci. An Off. Publ. Eur. Pept. Soc."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.peptides.2008.05.008","article-title":"Isolation, characterization and molecular cloning of new temporins from the skin of the North African ranid Pelophylax saharica","volume":"29","author":"Abbassi","year":"2008","journal-title":"Peptides"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.3390\/molecules20022775","article-title":"The role of phosphoglycans in the susceptibility of Leishmania mexicana to the temporin family of anti-microbial peptides","volume":"20","author":"Eggimann","year":"2015","journal-title":"Molecules"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.nano.2013.09.003","article-title":"Anti-leishmanial activity of the antimicrobial peptide DRS 01 observed in Leishmania infantum (syn. Leishmania chagasi) cells","volume":"10","author":"Eaton","year":"2014","journal-title":"Nanomedicine"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.bbrc.2006.06.168","article-title":"Novel dermaseptins from Phyllomedusa hypochondrialis (Amphibia)","volume":"347","author":"Brand","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"33464","DOI":"10.1074\/jbc.M001491200","article-title":"Isolation and characterization of gomesin, an 18-residue cysteine-rich defense peptide from the spider Acanthoscurria gomesiana hemocytes with sequence similarities to horseshoe crab antimicrobial peptides of the tachyplesin family","volume":"275","author":"Silva","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0166-6851(02)00300-6","article-title":"Induction of autophagic cell death in Leishmania donovani by antimicrobial peptides","volume":"127","author":"Bera","year":"2003","journal-title":"Mol. Biochem. Parasitol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.exppara.2009.03.019","article-title":"Leishmania donovani: Thionins, plant antimicrobial peptides with leishmanicidal activity","volume":"122","author":"Molina","year":"2009","journal-title":"Exp. Parasitol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.peptides.2011.01.011","article-title":"Leishmanicidal activity of synthetic antimicrobial peptides in an infection model with human dendritic cells","volume":"32","author":"Lozano","year":"2011","journal-title":"Peptides"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1111\/j.1365-2958.2006.05459.x","article-title":"The major surface-metalloprotease of the parasitic protozoan, Leishmania, protects against antimicrobial peptide-induced apoptotic killing","volume":"62","author":"Kulkarni","year":"2006","journal-title":"Mol. Microbiol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"15496","DOI":"10.1074\/jbc.M809079200","article-title":"Antimicrobial peptide-induced apoptotic death of leishmania results from calcium-dependent, caspase-independent mitochondrial toxicity","volume":"284","author":"Kulkarni","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1007\/s00436-014-3847-3","article-title":"Design of protease-resistant pexiganan enhances antileishmanial activity","volume":"113","author":"Kulkarni","year":"2014","journal-title":"Parasitol. Res."},{"key":"ref_173","unstructured":"WHO Malaria. Fact Sheet No. 94 April 2015. http:\/\/www.who.int\/mediacentre\/factsheets\/fs094\/en\/."},{"key":"ref_174","unstructured":"WHO Guidelines for the Treatment of Malaria. http:\/\/apps.who.int\/iris\/bitstream\/10665\/162441\/1\/9789241549127_eng.pdf."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/ja.2012.89","article-title":"In vitro activity of Pheroid vesicles containing antibiotics against Plasmodium falciparum","volume":"65","author":"Maritz","year":"2012","journal-title":"J. Antibiot."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1128\/AAC.44.9.2442-2451.2000","article-title":"Antimalarial activities of dermaseptin S4 derivatives","volume":"44","author":"Krugliak","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"e1003790","DOI":"10.1371\/journal.ppat.1003790","article-title":"Killer bee molecules: Antimicrobial peptides as effector molecules to target sporogonic stages of Plasmodium","volume":"9","author":"Carter","year":"2013","journal-title":"PLoS Pathog."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.exppara.2007.01.022","article-title":"Effect of the antimicrobial peptide gomesin against different life stages of Plasmodium spp","volume":"116","author":"Moreira","year":"2007","journal-title":"Exp. Parasitol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jtbi.2009.06.016","article-title":"Why do larval helminths avoid the gut of intermediate hosts?","volume":"260","author":"Parker","year":"2009","journal-title":"J. Theor. Biol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.micron.2003.12.001","article-title":"Microscopy and the helminth parasite","volume":"35","author":"Halton","year":"2004","journal-title":"Micron"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1172\/JCI34261","article-title":"Helminth infections: The great Neglected tropical diseases","volume":"118","author":"Hotez","year":"2008","journal-title":"J. Clin. Investig."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1136\/bmj.327.7412.431","article-title":"Helminthic infections","volume":"327","author":"Awasthi","year":"2003","journal-title":"Br. Med. J."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2307\/3285768","article-title":"How Much Human Helminthiasis Is There in the World?","volume":"85","author":"Crompton","year":"1999","journal-title":"J. Parasitol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1017\/S0031182000006491","article-title":"Malnutrition and parasitic helminth infections","volume":"121","author":"Stephenson","year":"2000","journal-title":"Parasitology"},{"key":"ref_185","unstructured":"WHO (1999). World Heatlh Report 1999, World Health Organization."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nri2199","article-title":"Protective immune mechanisms in helminth infection","volume":"7","author":"Anthony","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.actatropica.2012.08.002","article-title":"Usefulness of pumpkin seeds combined with areca nut extract in community-based treatment of human taeniasis in northwest Sichuan Province, China","volume":"124","author":"Li","year":"2012","journal-title":"Acta Trop."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1017\/S0031182010000272","article-title":"Taenia solium: Current understanding of laboratory animal models of taeniosis","volume":"137","author":"Flisser","year":"2010","journal-title":"Parasitology"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1128\/CVI.05428-11","article-title":"Detection of Taenia solium Taeniasis Coproantigen Is an Early Indicator of Treatment Failure for Taeniasis","volume":"19","author":"Bustos","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_190","unstructured":"WHO Taeniasis\/ cysticercosis: Fact Sheet N\u00b0 376. Available online: http:\/\/www.who.int\/mediacentre\/factsheets\/fs376\/en\/#."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0140-6736(03)14117-7","article-title":"Taenia solium cysticercosis","volume":"362","author":"Gonzalez","year":"2003","journal-title":"Lancet"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"10957","DOI":"10.1007\/s11033-012-1997-x","article-title":"Cathelicidins: Family of antimicrobial peptides. A review","volume":"39","author":"Lisowski","year":"2012","journal-title":"Mol. Biol. Rep."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.molbiopara.2008.12.006","article-title":"Antimicrobial peptides (Temporin A and Iseganan IB-367): Effect on the cysticerci of Taenia crassiceps","volume":"164","author":"Landa","year":"2009","journal-title":"Mol. Biochem. Parasitol."},{"key":"ref_194","unstructured":"WHO Onchocerciasis: Fact Sheet N\u00b0 374. Available online: http:\/\/www.who.int\/mediacentre\/factsheets\/fs374\/en\/#."},{"key":"ref_195","unstructured":"CDC Parasites\u2014Onchocerciasis (also known as River Blindness), Available online: http:\/\/www.cdc.gov\/parasites\/onchocerciasis\/."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1179\/000349802125000637","article-title":"Rapid epidemiological mapping of onchocerciasis (REMO): Its application by the African Programme for Onchocerciasis Control (APOC)","volume":"96","author":"Noma","year":"2002","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"ref_197","doi-asserted-by":"crossref","unstructured":"Tekle, A.H., Elhassan, E., Isiyaku, S., Amazigo, U.V., Bush, S., Noma, M., Cousens, S., Abiose, A., and Remme, J. H. (2012). Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: First evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control. Parasites Vectors, 5.","DOI":"10.1186\/1756-3305-5-28"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1006\/bbrc.1996.0616","article-title":"Host-Parasite Interaction in Human Onchocerciasis: Identification and Sequence Analysis of a Novel Human Calgranulin","volume":"221","author":"Marti","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1172\/JCI112120","article-title":"Defensins. Natural peptide antibiotics of human neutrophils","volume":"76","author":"Ganz","year":"1985","journal-title":"J. Clin. Investig."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1172\/JCI35740","article-title":"Neutrophil primary granule proteins HBP and HNP1-3 boost bacterial phagocytosis by human and murine macrophages","volume":"118","author":"Soehnlein","year":"2008","journal-title":"J. Clin. Investig."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1007\/s00018-007-6475-6","article-title":"Cationic host defence peptides: Innate immune regulatory peptides as a novel approach for treating infections","volume":"64","author":"Mookherjee","year":"2007","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s40259-013-0039-0","article-title":"Cationic host defence peptides: Potential as antiviral therapeutics","volume":"27","author":"Currie","year":"2013","journal-title":"BioDrugs"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1386-6532(01)00167-6","article-title":"Antiviral drugs: Current state of the art","volume":"22","year":"2001","journal-title":"J. Clin. Virol."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ijantimicag.2003.07.022","article-title":"Antiviral activity of antimicrobial cationic peptides against Junin virus and herpes simplex virus","volume":"23","author":"Castilla","year":"2004","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1023\/B:BIOM.0000027691.86757.e2","article-title":"The antimicrobial activity of lactoferrin: Current status and perspectives","volume":"17","author":"Orsi","year":"2004","journal-title":"Biometals"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"14318","DOI":"10.1128\/JVI.79.22.14318-14329.2005","article-title":"Human beta-defensins suppress human immunodeficiency virus infection: Potential role in mucosal protection","volume":"79","author":"Sun","year":"2005","journal-title":"J. Virol."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0166-3542(01)00195-4","article-title":"Antiviral activities of lactoferrin","volume":"52","author":"Beljaars","year":"2001","journal-title":"Antivir. Res."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s100960050457","article-title":"Evaluation of the inactivation of infectious Herpes simplex virus by host-defense peptides","volume":"19","author":"Yasin","year":"2000","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1128\/jvi.60.3.1068-1074.1986","article-title":"Direct inactivation of viruses by human granulocyte defensins","volume":"60","author":"Daher","year":"1986","journal-title":"J. Virol."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0928-8244(03)00106-8","article-title":"Rhinovirus increases human beta-defensin-2 and -3 mRNA expression in cultured bronchial epithelial cells","volume":"38","author":"Duits","year":"2003","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1073\/pnas.0508033103","article-title":"Human alpha-defensins block papillomavirus infection","volume":"103","author":"Buck","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1590\/S0074-02762007005000028","article-title":"In vitro antiviral activity of antimicrobial peptides against herpes simplex virus 1, adenovirus, and rotavirus","volume":"102","author":"Kratz","year":"2007","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.ceb.2004.09.011","article-title":"Death by design: Apoptosis, necrosis and autophagy","volume":"16","author":"Edinger","year":"2004","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_214","first-page":"476","article-title":"Induction and function of type I and III interferon in response to viral infection","volume":"1","author":"Levy","year":"2011","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.immuni.2006.08.007","article-title":"Type I interferons in host defense","volume":"25","author":"Stetson","year":"2006","journal-title":"Immunity"},{"key":"ref_216","doi-asserted-by":"crossref","unstructured":"Randall, R.E., and Goodbourn, S. (2008). Interferons and viruses: An interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol., 89.","DOI":"10.1099\/vir.0.83391-0"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1600-065X.2008.00737.x","article-title":"Innate immunity to virus infection","volume":"227","author":"Takeuchi","year":"2009","journal-title":"Immunol. Rev."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1086\/521027","article-title":"Alpha-Defensin inhibits influenza virus replication by cell-mediated mechanism(s)","volume":"196","author":"Salvatore","year":"2007","journal-title":"J. Infect. Dis."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2165\/00003495-200363040-00005","article-title":"Antimicrobial peptides: Current status and therapeutic potential","volume":"63","author":"Koczulla","year":"2003","journal-title":"Drugs"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"e890","DOI":"10.1371\/journal.pntd.0000890","article-title":"Americas Dengue Prevention Boards Surveillance Working, G., Best practices in dengue surveillance: A report from the Asia-Pacific and Americas Dengue Prevention Boards","volume":"4","author":"Beatty","year":"2010","journal-title":"PLoS Negl.Trop. Dis."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev.ento.53.103106.093326","article-title":"Dengue virus-mosquito interactions","volume":"53","author":"Halstead","year":"2008","journal-title":"Ann. Rev. Entomol."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1126\/science.239.4839.476","article-title":"Pathogenesis of dengue: Challenges to molecular biology","volume":"239","author":"Halstead","year":"1988","journal-title":"Science"},{"key":"ref_223","doi-asserted-by":"crossref","unstructured":"Normile, D. (2013). Tropical medicine. Surprising new dengue virus throws a spanner in disease control efforts. Science, 342.","DOI":"10.1126\/science.342.6157.415"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"9591","DOI":"10.1128\/JVI.02776-06","article-title":"Evolutionary processes among sylvatic dengue type 2 viruses","volume":"81","author":"Vasilakis","year":"2007","journal-title":"J. Virol."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1007\/s00018-010-0357-z","article-title":"Dengue virus life cycle: Viral and host factors modulating infectivity","volume":"67","author":"Wilschut","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0378-1119(92)90216-C","article-title":"Lack of evidence for proofreading mechanisms associated with an RNA virus polymerase","volume":"122","author":"Steinhauer","year":"1992","journal-title":"Gene"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1006\/viro.2002.1549","article-title":"Extinction and rapid emergence of strains of dengue 3 virus during an interepidemic period","volume":"301","author":"Wittke","year":"2002","journal-title":"Virology"},{"key":"ref_228","unstructured":"CDC Dengue and the Aedes aegypti Mosquito, http:\/\/www.cdc.gov\/dengue\/resources\/30Jan2012\/aegyptifactsheet.pdf."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"e2055","DOI":"10.1371\/journal.pntd.0002055","article-title":"Economic and disease burden of dengue in Southeast Asia","volume":"7","author":"Shepard","year":"2013","journal-title":"PLoS Negl.Trop. Dis."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nri3014","article-title":"Immunity to dengue virus: A tale of original antigenic sin and tropical cytokine storms","volume":"11","author":"Rothman","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"20983","DOI":"10.1074\/jbc.M602168200","article-title":"Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity","volume":"281","author":"Kozlov","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_233","doi-asserted-by":"crossref","unstructured":"Rothan, H.A., Bahrani, H., Rahman, N.A., and Yusof, R. (2014). Identification of natural antimicrobial agents to treat dengue infection: In vitro analysis of latarcin peptide activity against dengue virus. BMC Microbiol., 14.","DOI":"10.1186\/1471-2180-14-140"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0065-3527(03)59002-9","article-title":"Molecular biology of flaviviruses","volume":"59","author":"Lindenbach","year":"2003","journal-title":"Adv. Virus Res."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.mib.2008.06.004","article-title":"Structural proteomics of dengue virus","volume":"11","author":"Perera","year":"2008","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1128\/JVI.06225-11","article-title":"Ligand-bound structures of the dengue virus protease reveal the active conformation","volume":"86","author":"Noble","year":"2012","journal-title":"J. Virol."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"719","DOI":"10.7150\/ijms.5037","article-title":"Inhibition of dengue virus entry into target cells using synthetic antiviral peptides","volume":"10","author":"Alhoot","year":"2013","journal-title":"Int. J. Med. Sci."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"8765","DOI":"10.1128\/jvi.70.12.8765-8772.1996","article-title":"Demonstration of binding of dengue virus envelope protein to target cells","volume":"70","author":"Chen","year":"1996","journal-title":"J. Virol."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nature02165","article-title":"Structure of the dengue virus envelope protein after membrane fusion","volume":"427","author":"Modis","year":"2004","journal-title":"Nature"},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"e107539","DOI":"10.1371\/journal.pone.0107539","article-title":"Right place, wrong species: A 20-year review of rabies virus cross species transmission among terrestrial mammals in the United States","volume":"9","author":"Wallace","year":"2014","journal-title":"PLoS ONE"},{"key":"ref_241","first-page":"304","article-title":"Estimating human rabies mortality in the United Republic of Tanzania from dog bite injuries","volume":"80","author":"Cleaveland","year":"2002","journal-title":"Bull. World Health Organ."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrmicro2260","article-title":"The cell biology of rabies virus: Using stealth to reach the brain","volume":"8","author":"Schnell","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_243","unstructured":"WHO Rabies Fact Sheet N\u00b0 99. Available online: http:\/\/www.who.int\/mediacentre\/factsheets\/fs099\/en\/."},{"key":"ref_244","unstructured":"Fields, B.N., Knipe, D.M., Howley, P.M., Griffin, D.E., Lamb, R.A., Martin, M.A., Roizman, B., and Straus, S.E. (2007). Rhabdoviridae. Fields\u2019 Virology, Williams and Wilkins."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"7673","DOI":"10.1128\/JVI.79.12.7673-7681.2005","article-title":"Identification of the rabies virus alpha\/beta interferon antagonist: Phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3","volume":"79","author":"Brzozka","year":"2005","journal-title":"J. Virol."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0165-0270(00)00296-X","article-title":"Rabies as a transneuronal tracer of circuits in the central nervous system","volume":"103","author":"Kelly","year":"2000","journal-title":"J. Neurosci. Methods"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/0035-9203(76)90037-7","article-title":"The clinical picture of rabies in man","volume":"70","author":"Warrell","year":"1976","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_248","first-page":"1","article-title":"Advisory Committee on Immunization Practices Centers for Disease, C.; Prevention, Human rabies prevention\u2014United States, 2008: Recommendations of the Advisory Committee on Immunization Practices","volume":"57","author":"Manning","year":"2008","journal-title":"MMWR Recomm. Rep."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"6405","DOI":"10.1016\/j.vaccine.2008.08.069","article-title":"Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene","volume":"26","author":"Cenna","year":"2008","journal-title":"Vaccine"},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/S0264-410X(02)00143-3","article-title":"Rabies DNA vaccination of non-human primates: Post-exposure studies using gene gun methodology that accelerates induction of neutralizing antibody and enhances neutralizing antibody titers","volume":"20","author":"Lodmell","year":"2002","journal-title":"Vaccine"},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"6295","DOI":"10.1016\/j.vaccine.2008.04.087","article-title":"Fighting rabies in Africa: The Africa Rabies Expert Bureau (AfroREB)","volume":"26","author":"Dodet","year":"2008","journal-title":"Vaccine"},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"7410","DOI":"10.1128\/JVI.78.14.7410-7417.2004","article-title":"Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides","volume":"78","author":"Real","year":"2004","journal-title":"J. Virol."},{"key":"ref_253","unstructured":"A Database of Antiviral Peptides. Available online: http:\/\/crdd.osdd.net\/servers\/avpdb\/browse.php?by=Rabies%20virus&TYPE=Virus."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"9613","DOI":"10.1128\/JVI.75.20.9613-9622.2001","article-title":"Functional interaction map of lyssavirus phosphoprotein: Identification of the minimal transcription domains","volume":"75","author":"Jacob","year":"2001","journal-title":"J. Virol."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/glycob\/8.2.121","article-title":"The role of site-specific N-glycosylation in secretion of soluble forms of rabies virus glycoprotein","volume":"8","author":"Wojczyk","year":"1998","journal-title":"Glycobiology"},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2761.2012.01448.x","article-title":"Antiviral activity of casein and alphas2 casein hydrolysates against the infectious haematopoietic necrosis virus, a rhabdovirus from salmonid fish","volume":"36","author":"Carrillo","year":"2013","journal-title":"J. Fish Dis."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.antiviral.2007.06.006","article-title":"Dual antiviral activity of human alpha-defensin-1 against viral haemorrhagic septicaemia rhabdovirus (VHSV): Inactivation of virus particles and induction of a type I interferon-related response","volume":"76","author":"Falco","year":"2007","journal-title":"Antivir. Res."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"6973","DOI":"10.1007\/s00253-014-5728-1","article-title":"Expression and purification of cyto-insectotoxin (Cit1a) using silkworm larvae targeting for an antimicrobial therapeutic agent","volume":"98","author":"Ali","year":"2014","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.peptides.2010.08.008","article-title":"Cost-effective expression and purification of antimicrobial and host defense peptides in Escherichia coli","volume":"31","author":"Bommarius","year":"2010","journal-title":"Peptides"},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.pep.2011.08.001","article-title":"Recombinant production of antimicrobial peptides in Escherichia coli: A review","volume":"80","author":"Li","year":"2011","journal-title":"Protein Expr. Purif."}],"updated-by":[{"DOI":"10.3390\/molecules200916757","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2015,8,24]],"date-time":"2015-08-24T00:00:00Z","timestamp":1440374400000}}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/20\/8\/15392\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T22:57:22Z","timestamp":1754261842000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/20\/8\/15392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,24]]},"references-count":260,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2015,8]]}},"alternative-id":["molecules200815392"],"URL":"https:\/\/doi.org\/10.3390\/molecules200815392","relation":{"correction":[{"id-type":"doi","id":"10.3390\/molecules200916757","asserted-by":"object"}]},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,24]]}}}